"3' Untranslated Regions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The sequence at the 3' end of messenger RNA that does not code for product. This region contains transcription and translation regulating sequences.
| Descriptor ID |
D020413
|
| MeSH Number(s) |
D13.444.735.544.875.880 D13.444.735.790.878.880 G05.360.340.024.220.880.880 G05.360.340.024.340.137.910.880
|
| Concept/Terms |
3' Untranslated Regions- 3' Untranslated Regions
- 3'UTR
- 3'UTRs
- 3' Untranslated Region
- Region, 3' Untranslated
- Regions, 3' Untranslated
- Untranslated Region, 3'
- Untranslated Regions, 3'
- 3' UTR
- 3' UTRs
- UTR, 3'
- UTRs, 3'
|
Below are MeSH descriptors whose meaning is more general than "3' Untranslated Regions".
Below are MeSH descriptors whose meaning is more specific than "3' Untranslated Regions".
This graph shows the total number of publications written about "3' Untranslated Regions" by people in this website by year, and whether "3' Untranslated Regions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 2 | 2 |
| 2001 | 1 | 4 | 5 |
| 2002 | 0 | 2 | 2 |
| 2003 | 3 | 4 | 7 |
| 2004 | 1 | 3 | 4 |
| 2005 | 2 | 3 | 5 |
| 2006 | 0 | 5 | 5 |
| 2007 | 2 | 4 | 6 |
| 2008 | 3 | 7 | 10 |
| 2009 | 2 | 9 | 11 |
| 2010 | 1 | 12 | 13 |
| 2011 | 3 | 6 | 9 |
| 2012 | 3 | 6 | 9 |
| 2013 | 0 | 15 | 15 |
| 2014 | 6 | 12 | 18 |
| 2015 | 2 | 15 | 17 |
| 2016 | 3 | 10 | 13 |
| 2017 | 0 | 9 | 9 |
| 2018 | 3 | 4 | 7 |
| 2019 | 5 | 11 | 16 |
| 2020 | 0 | 6 | 6 |
| 2021 | 0 | 10 | 10 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "3' Untranslated Regions" by people in Profiles.
-
DDX3 regulates cancer immune surveillance via 3' UTR-mediated cell-surface expression of PD-L1. Cell Rep. 2024 Mar 26; 43(3):113937.
-
Alternative cleavage and polyadenylation of the Ccnb1 mRNA defines accumulation of cyclin protein during the meiotic cell cycle. Nucleic Acids Res. 2024 Feb 09; 52(3):1258-1271.
-
MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells. Endocr Relat Cancer. 2023 11 01; 30(11).
-
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1. J Neurooncol. 2023 Jul; 163(3):623-634.
-
Alternative polyadenylation alters protein dosage by switching between intronic and 3'UTR sites. Sci Adv. 2023 02 17; 9(7):eade4814.
-
Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer. Cancer Res. 2023 01 04; 83(1):59-73.
-
3'UTR shortening of profibrotic genes and reversibility of fibrosis in patients with end-stage right ventricular failure. Clin Transl Med. 2022 09; 12(9):e1017.
-
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial. Leukemia. 2022 10; 36(10):2479-2487.
-
Systematic Evaluation of HLA-G 3'Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome. Front Immunol. 2021; 12:817132.
-
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGF?R3. J Invest Dermatol. 2022 07; 142(7):1956-1965.e2.